Pacific Pharm's Meditoxin eyes bigger market share

Published: 2006-07-05 06:56:00

Updated: 2006-07-05 06:56:00

Pacific Pharm plans to expand its share of the domestic botulinum toxin market dominated by foreign brands Allergan's Botox, Ipsen's Dysport, Chinese labs' BTX-A - and the market is expected to enter fierce competition.

Meditoxin, the first-domestically-made botulinum toxin type A neurotoxin ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK